Previous 10 | Next 10 |
REDWOOD CITY, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for severe lung disease, today reported financial results for the second quarter ended June 30, 2021. ...
REDWOOD CITY, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG), a global leader in minimally invasive treatments for severe lung disease, welcomes Alissa Hsu Lynch and Tiffany Sullivan to its Board of Directors. Ms. Lynch will serve as a member of the Audit Commi...
REDWOOD CITY, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Canaccord Genuity 41 s...
Newly Published Data Shows Positive, Durable Benefits of the Only Minimally Invasive Treatment Approved for Patients with Homogeneous Emphysema, a Form of Severe COPD with Widespread Destruction of Lung Tissue Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”),...
REDWOOD CITY, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2021 after the close of t...
REDWOOD CITY, Calif., May 17, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced that key long-term follow-up data from the TRANSFORM ® study was presente...
The following slide deck was published by Pulmonx Corporation in conjunction with their 2021 Q1 earnings call. For further details see: Pulmonx Corporation 2021 Q1 - Results - Earnings Call Presentation
Pulmonx Corporation (LUNG) Q1 2021 Results Conference Call May 04, 2021 04:30 PM ET Company Participants Brian Johnston - IR, Gilmartin Group Glen French - President and CEO Derrick Sung - CFO Conference Call Participants Bob Hopkins - Bank of America Marissa Bych - Morgan Stanley Rick Wise -...
Image source: The Motley Fool. Pulmonx Corporation (NASDAQ: LUNG) Q1 2021 Earnings Call May 04, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Pulmonx Corporation (LUNG) Q1 2021 Earnings Call Transcript
Pulmonx (LUNG): Q1 GAAP EPS of -$0.34 beats by $0.05.Revenue of $9.2M beats by $1.06M.Press Release For further details see: Pulmonx EPS beats by $0.05, beats on revenue
News, Short Squeeze, Breakout and More Instantly...
2024-07-12 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
REDWOOD CITY, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2024 after the close of trading...
2024-06-23 01:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...